fbpx

Our Work

We’re accelerating health equity by delivering medication, technology, and services to people facing cancer and other critical illnesses.

What differentiates The Max Foundation
in its work.

Learn more about how The Max Foundation addresses the complex barriers of health inequities in low- and middle-income countries.

Global Health Inequities

The Global Treatment Gap

Managing cancer in low- and middle-income countries is challenging. Routine pathology, diagnostic exams, and standard medicines are often unavailable. Patients may also be diagnosed at later stages and receive inadequate treatment because of limited resources in low- and middle-income countries:

  • 7M

    cancer-related deaths each year

  • 75%

    of cancer-related deaths over the next decade predicted to occur there

  • 15%

    Less than 15% of countries have cancer treatment available, compared to more than 90% in high-income countries

Read More

Changing Systems, Challenging Perceptions

Advancing cancer treatment for all

Our focus is developing the systems needed to deliver life-saving medication safely and effectively to patients, demonstrating that it can indeed be done. The Max Foundation wants to change perceptions so it will no longer be acceptable to leave these patients behind.

Providing access to medication

We’ve provided access to diagnostics and life- extending treatment to more than 100,000 since we started.

Providing access to diagnostics

The right equipment helps physicians make informed decisions and adjust treatment as needed. We facilitate access to test kits and diagnostics equipment, establish molecular diagnostics infrastructure, and work with partners to educate patients and caregivers.

Building social support systems

Living with a rare disease can be deeply isolating. Those enrolled in our program receive support from physicians, Max team members, and fellow patients.

Strengthening health systems

With our distribution partners and network of healthcare professionals, we’ve built an efficient and validated supply chain that safely delivers medicine around the world.

Where we work

The Max Foundation provides support for people living with cancer around the world.

Africa & Middle East
9,628 cancer patients across 15 diseases through 82 treating physicians
Asia Pacific
654 cancer patients across 5 diseases through 44 treating physicians
Eastern Europe & Central Asia
4,685 cancer patients across 11 diseases through 19 treating physicians
Latin America
3,501 cancer patients across 9 diseases through 107 treating physicians
South Asia
13,360 cancer patients across 12 diseases through 293 treating physicians

Our Collaborative Programs

For more than 25 years, The Max Foundation and its partners have created practical, scalable solutions to reach more people living with cancer. We provide access to life-extending medication for chronic myeloid leukemia, gastrointestinal stromal tumor, advanced breast cancer, renal cell carcinoma, chronic lymphocytic leukemia, lung cancer, and more.

  • Max Access Solutions

    Our innovative model delivers life- extending treatment to people living with cancer. Through Max Access Solutions, we receive donations of medication from pharmaceutical companies and channel it to countries where those treatments are not locally available.

    Learn More
  • Overcoming Barriers to Access

    Improving health outcomes for people living with cancer is about more than medication. We provide access to psychosocial support, transportation assistance, adherence monitoring, and more to ensure patient needs are handled individually and holistically.

    Learn More
  • Max GPS

    In 2023, we launched Max GPS. It’s a patient navigation program that assists people affected by cancer free of charge, especially those who are underserved
    like refugee and migrant communities.

    Learn More